PUNE, India, March 3, 2016 /PRNewswire/ --
Recently concluded and co-located, Biomarker Conference, NGS Data Analysis and Informatics Conference and Genome Editing & Engineering Conference, organized by MarketsandMarkets Conferences were a huge success. Held at the Fourpoints, San Diego, on 18th and 19th February 2016, the event saw participation from global pharma, bio-pharma companies, research institutions and solution provider organizations.
The Biomarker Conference agenda was designed to discuss and work on emerging pathways and breakthroughs in biomarker discovery and successful validation in tandem with the regulatory guidelines. The key note address on day one saw presentations by Dr. Sudhir Srivastava, Chief, Cancer Biomarkers, NCI/NIH and Dr. Abraham Tzou, Medical Officer, Center for Devices and Radiological Health, FDA. Organizations such as Genpro, Cancer Genetics, Celerion, Centogene, BioAgilytix, Nanomedical Diagnostics, ArcherDX, Personal Genome Diagnostics, Abcam, Excelra, MedGenome, ResearcDx, KCAS, DxTerity, MicroConstants and Rosetta Genomics showcased and talked about their latest products and solutions.
Dr. Platero, Sr. Director of Translational Research Oncology at Janssen Research & Development, one of the key speakers at the conference, speaking about biomarkers and their interesting aspects during his presentation said, "It is the ability to straddle the bench and clinic, developing a hypothesis in the laboratory and applying them in clinical trials and also developing the hypothesis in the clinical trial and going back to the lab. This way we are helping a lot of patients."
With constantly evolving gene editing tools, researchers and scientists working on genome engineering and editing now have many options to decide on the most accurate tools for their research. The question faced by many experts is - which is the right tool for my research? With an aim to discuss the advantages, utilities and challenges of various gene editing tools, Genome Editing & Engineering Conference was held for professionals working in genome engineering, animal models, rare diseases, disease modeling, translational medicine, drug discovery and target identification/validation principles. Lonza, Sigma Aldrich, ThermoFisher, Cibus, Desktop Genetics and Agilent Technologies showcased their offerings, giving updates on advanced CRISPR applications and how their tools can aid the efforts of researchers.
Recently, there have been major developments in the genomics domain with next generation sequencing technology playing a pivotal role. Analysis, interpretation, access and storage of data gathered using NGS is important, be it for disease diagnosis, prognosis or drug discovery. With a view to leverage the NGS technology to its fullest potential, the conference agenda was designed to focus on application, analysis, validation, regulations and informatics related to the NGS data. Organizations such as Seven Bridges, Molecular Health, Illumina, DNA Nexus, MedGenome, Desktop Gentics, Data4Cure and Arima, were happy to meet delegates from NCTR/FDA, GSK, Janssen, Roche, Biogen, New York Genome Center, Eisai, Harvard Medical School and The Broad Institute and discuss their products.
The delegates were happy to network with global experts under one roof and learn about new developments. The next edition based on the positive feedback of delegates will be held in February 2017 in San Diego - USA.
About MarketsandMarkets Conferences:
MarketsandMarkets Conferences (MnM Conferences) produces global summits, congresses and conferences bringing together key industry experts from academia and industry sharing and exchanging ideas and latest research through cutting edge conference programs and interactive panel and round table discussions.
Tel: +91-20-6708 0270
SOURCE MarketsandMarkets Conferences